Search research articles
Contact Us
Filters
Showing results (71-80 of 222) with videos related to
Page
of 23
Sort By:
Journal for Immunotherapy of Cancer
|
September 20, 2017
Checkpoint inhibitor is active against large cell neuroendocrine carcinoma with high tumor mutation burden
Victoria E Wang, Anatoly Urisman, Lee Albacker, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 23, 2021
Large remodeling of the Myc-induced cell surface proteome in B cells and prostate cells creates new opportunities for immunotherapy
Wentao Chen, Kurt Yun Mou, Paige Solomon, et al.
Archives of Dermatological Research
|
May 5, 2025
Arctic & Antarctic dermatology: a narrative review of cutaneous conditions of polar explorers and researchers
Ryan Scheinkman, Rahul Aggarwal, Rachel Summers, et al.
Clinical Genitourinary Cancer
|
January 7, 2024
Oral Toxicities of PSMA-Targeted Immunotherapies for The Management of Prostate Cancer
Chitra Priya Emperumal, Alessandro Villa, Caleb Hwang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 11, 2022
Phase Ib Study of the BET Inhibitor GS-5829 as Monotherapy and Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer
Rahul Aggarwal, Alexander N Starodub, Brian D Koh, et al.
Journal of the American College of Cardiology
|
March 19, 2021
Rural-Urban Disparities: Diabetes, Hypertension, Heart Disease, and Stroke Mortality Among Black and White Adults, 1999-2018
Rahul Aggarwal, Nicholas Chiu, Eméfah C Loccoh, et al.
Clinical Genitourinary Cancer
|
May 3, 2014
Response to subsequent docetaxel in a patient cohort with metastatic castration-resistant prostate cancer after abiraterone acetate treatment
Rahul Aggarwal, Anna Harris, Carl Formaker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 18, 2018
Reply to A. Dalla Volta et al
Rahul Aggarwal, Jiaoti Huang, Joshi Alumkal, et al.
Plos One
|
October 26, 2017
The MELD-Plus: A generalizable prediction risk score in cirrhosis
Uri Kartoun, Kathleen E Corey, Tracey G Simon, et al.
Annals of Internal Medicine
|
February 24, 2025
Prevalence of Chronic Medical Conditions Among Medicare Advantage and Traditional Medicare Beneficiaries
Andrew S Oseran, Rahul Aggarwal, Jose Figueroa, et al.
Page
of 23
Search research articles
Search
Showing results (71-80 of 222) with videos related to
Sort By:
Page
of 23
Journal for Immunotherapy of Cancer
|
September 20, 2017
Checkpoint inhibitor is active against large cell neuroendocrine carcinoma with high tumor mutation burden
Victoria E Wang, Anatoly Urisman, Lee Albacker, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 23, 2021
Large remodeling of the Myc-induced cell surface proteome in B cells and prostate cells creates new opportunities for immunotherapy
Wentao Chen, Kurt Yun Mou, Paige Solomon, et al.
Archives of Dermatological Research
|
May 5, 2025
Arctic & Antarctic dermatology: a narrative review of cutaneous conditions of polar explorers and researchers
Ryan Scheinkman, Rahul Aggarwal, Rachel Summers, et al.
Clinical Genitourinary Cancer
|
January 7, 2024
Oral Toxicities of PSMA-Targeted Immunotherapies for The Management of Prostate Cancer
Chitra Priya Emperumal, Alessandro Villa, Caleb Hwang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 11, 2022
Phase Ib Study of the BET Inhibitor GS-5829 as Monotherapy and Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer
Rahul Aggarwal, Alexander N Starodub, Brian D Koh, et al.
Journal of the American College of Cardiology
|
March 19, 2021
Rural-Urban Disparities: Diabetes, Hypertension, Heart Disease, and Stroke Mortality Among Black and White Adults, 1999-2018
Rahul Aggarwal, Nicholas Chiu, Eméfah C Loccoh, et al.
Clinical Genitourinary Cancer
|
May 3, 2014
Response to subsequent docetaxel in a patient cohort with metastatic castration-resistant prostate cancer after abiraterone acetate treatment
Rahul Aggarwal, Anna Harris, Carl Formaker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 18, 2018
Reply to A. Dalla Volta et al
Rahul Aggarwal, Jiaoti Huang, Joshi Alumkal, et al.
Plos One
|
October 26, 2017
The MELD-Plus: A generalizable prediction risk score in cirrhosis
Uri Kartoun, Kathleen E Corey, Tracey G Simon, et al.
Annals of Internal Medicine
|
February 24, 2025
Prevalence of Chronic Medical Conditions Among Medicare Advantage and Traditional Medicare Beneficiaries
Andrew S Oseran, Rahul Aggarwal, Jose Figueroa, et al.
Page
of 23